Kinase Biology Services Market to Grow with a CAGR of 10.12% through 2028
Rising
advancements in high-throughput screening (HTS) technologies is expected to
drive the Global Kinase Biology Services Market growth in the forecast period,
2024-2028.
According
to TechSci Research report, “Kinase Biology Services Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2028”, the Global Kinase Biology Services Market stood at USD 73.02 billion
in 2022 and is anticipated to grow with a CAGR of 10.12% in the forecast
period, 2024-2028. The Global Kinase
Biology Services Market is experiencing robust growth, driven by a convergence
of factors that are reshaping the landscape of drug discovery and development.
Kinases, a class of enzymes pivotal in regulating various cellular processes,
have become central to research and therapeutic advancements across multiple
fields, from cancer to neurodegenerative diseases. One of the
primary drivers of the Kinase Biology Services Market is the escalating
incidence of chronic diseases, especially cancer.
Kinases play a
critical role in cell signaling pathways, and their dysregulation is frequently
implicated in the development and progression of diseases like cancer,
inflammatory disorders, and cardiovascular conditions. As the global burden of
these diseases continues to grow, there is an increasing demand for
kinase-focused research to identify novel therapeutic targets and develop more
effective treatments.
The era of personalized medicine has ushered in a new paradigm in
healthcare, and kinases have emerged as prime targets for precision therapies.
Kinase inhibitors, designed to target specific genetic mutations and aberrant
kinase activity, have demonstrated remarkable success in treating various
cancers. This personalized approach allows for tailored treatments based on
individual patient profiles, and it is driving the demand for kinase biology
services to identify and validate kinase inhibitors that can be used in these
therapies.
High-throughput
screening technologies have revolutionized drug discovery and development, and
they are a cornerstone of kinase biology services. Recent advancements in HTS,
including robotics, automation, and data analysis tools, have significantly
improved the efficiency and throughput of kinase assays. This has not only
reduced the time and cost involved in kinase research but has also expanded the
scope and scale of kinase biology services, making them more accessible to a
wider range of organizations and research institutions. The field of
immunotherapy has gained significant traction in recent years as a promising
approach to cancer treatment.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Kinase Biology Services Market.”
Kinases are
integral in regulating immune cell signaling pathways, making them potential
targets for immunotherapy development. As interest in immunotherapy continues
to surge, kinase biology services are in high demand for identifying and
characterizing kinase inhibitors that can modulate the immune response and
enhance the effectiveness of immunotherapeutic interventions. Governments,
pharmaceutical companies, and private investors are allocating substantial
resources to support research and development efforts in the life sciences.
Funding for Kinase-focused projects, both basic and translational, has surged,
spurring innovation and driving the demand for kinase biology services. This
investment is expected to sustain market growth in the coming years.
The Global
Kinase Biology Services Market is segmented into derived cell type,
application, regional distribution, and company.
Based on type,
the Global Kinase Biology Services Market is segmented into ELISA Based
Tests, Enzymatic Tests,Colorimetric Assay Based Tests, and Others. Based on the
type, the ELISA based tests segment emerged as the dominant player in the
global market for Global Kinase Biology Services in 2022. ELISA (Enzyme-Linked
Immunosorbent Assay) is a versatile and crucial tool in kinase biology
services. Its ability to offer quantitative measurements of specific proteins,
including kinases, in biological samples provides researchers with valuable
insights into kinase activity, cellular signaling pathways, and protein-protein
interactions. ELISA-based assays have a wide range of applications, from
biomarker discovery, where they help identify disease markers, to drug
screening, enabling the evaluation of potential kinase inhibitors for
therapeutic development.
Based on
Application, the Global Kinase Biology Services Market is segmented into Diagnosis Use and Research Use.
Based on the Application, the research segment emerged as the dominant player
in the global market for Global Kinase Biology Services in 2022. Researchers use
kinase biology services to investigate the role of kinases in cellular
signaling pathways. Understanding how kinases function in different contexts is
essential for advancing our knowledge of cell biology. The development of
targeted therapies and kinase inhibitors is a prominent application of kinase
biology services in research. These services help identify and validate
potential drug candidates that target specific kinases involved in diseases
like cancer. Kinase biology services aid in the discovery of biomarkers
associated with kinase activity or dysregulation. These biomarkers can be used
for disease diagnosis and monitoring.
North America
emerged as the dominant player in the global Kinase Biology Services market in
2022, holding the largest market share. This is on account of several key
factors such as advanced healthcare infrastructure, Strong Research and
Development Ecosystem and high regulatory acceptance. The regulatory
environment for kinase biology in North America is relatively favorable, which
has encouraged companies to invest in this field. The US Food and Drug
Administration (FDA) has approved several kinase biology products, and is
actively working to develop guidance for the development and approval of kinase
biology-based therapies.
There is a high demand for kinase-based therapies, as they offer the
potential to treat a wide range of diseases, including cancer, heart disease,
and neurological disorders. North America is home to a large number of patients
with these diseases, which is driving the demand for kinase-based therapies.
Major companies
operating in Global Kinase Biology Services Market are:
- Thermo Fisher Scientific
- Roche Holdings
- Jena Bioscience GmbH
- Qiagen N.V.
- Merck & Co Company
- Promega Corporation
- Takara Bio
- Anchor
- Reaction Biology Corporation (RBC)
- Nanosyn, Inc
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The Global
Kinase Biology Services Market is poised for substantial growth in the coming
years due to several key factors. First and foremost, the rising incidence of
chronic diseases, such as cancer, neurodegenerative disorders, and
cardiovascular ailments, is driving the demand for kinase-related research and
services. Advancements in high-throughput screening (HTS) technologies are also
contributing to the market's growth. These technologies enable researchers to
conduct kinase assays efficiently and at a higher throughput, speeding up
early-stage drug discovery and kinase inhibitor screening. Additionally, the
integration of next-generation sequencing (NGS) into kinase biology services is
expanding the possibilities for research, allowing for a deeper understanding
of kinase-related alterations in various diseases. Moreover, increasing
investments in research and development (R&D) by governments,
pharmaceutical companies, and private investors are further propelling the
market. ” said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Global Kinase
Biology Services Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By
Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Neurons, Others),
By Application (Drug Development, Regenerative Medicine, Toxicity Testing,
Tissue Engineering, Cell Therapy, Disease Modeling), By End user (Research
Institutions, Other) By Region and Competition”, has evaluated
the future growth potential of Global Kinase Biology Services Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Kinase Biology Services Market.
Contact
Mr. Ken Mathews
708 Third
Avenue,
Manhattan, NY,
New York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com